Literature DB >> 33780962

Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Jie Xing1, Xue Guan1, Qian Zhang1, Shuohua Chen2, Shouling Wu2, Xiujing Sun1.   

Abstract

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is defined by the accumulation of triglycerides (TG). The body mass index (BMI) is associated with NAFLD. This large-scale cohort study was performed to evaluate and quantify the mediating effect of TG on the association between BMI and NAFLD.
METHODS: In total, 15,943 participants in the Kailuan Group were recruited between 2010 and 2014. The impact of TG on the association between BMI and NAFLD was determined through a mediation analysis.
RESULTS: BMI was an independent risk factor for incident NAFLD, with OR of 1.416 (95% CI 1.338-1.499) and 1.187 (95% CI 1.137-1.240) in the low-BMI and high-BMI groups, respectively (p < 0.001). The TG level was a risk factor for NAFLD in the high-BMI group, with an OR of 2.775 (95% CI 1.488-5.177; p = 0.001). Positive associations between BMI and the TG level remained in the 2 above mentioned groups after adjusting for confounders (β = 0.072 and 0.032; p < 0.001). The mediation analysis revealed that TG contributed to 26.050% of incident NAFLD in the high-BMI group (p = 0.01).
CONCLUSION: A high BMI was an independent risk factor for incident NAFLD, and a high TG level was a risk factor in the high-BMI group (BMI ≥24). TG contributes about 25% to incident NAFLD in people with obesity.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Body mass index; Nonalcoholic fatty liver disease; Obesity; Triglycerides

Year:  2021        PMID: 33780962      PMCID: PMC8138251          DOI: 10.1159/000514848

Source DB:  PubMed          Journal:  Obes Facts        ISSN: 1662-4025            Impact factor:   3.942


  31 in total

1.  Sleep and CKD in Chinese Adults: A Cross-Sectional Study.

Authors:  Junjuan Li; Zhe Huang; Jinhong Hou; Amy M Sawyer; Zhijun Wu; Jianfang Cai; Gary Curhan; Shouling Wu; Xiang Gao
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-07       Impact factor: 8.237

2.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  J Hepatol       Date:  2016-04-07       Impact factor: 25.083

3.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Takayuki Nakagawa; Hiroya Taniguchi; Kota Fujii; Tatsushi Omatsu; Tomoaki Nakajima; Hiroshi Sarui; Makoto Shimazaki; Takahiro Kato; Junichi Okuda; Kazunori Ida
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

4.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

5.  Longitudinal study of alcohol consumption and HDL concentrations: a community-based study.

Authors:  Shue Huang; Junjuan Li; Gregory C Shearer; Alice H Lichtenstein; Xiaoming Zheng; Yuntao Wu; Cheng Jin; Shouling Wu; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2017-03-01       Impact factor: 7.045

6.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

7.  The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.

Authors:  Su-Yeon Choi; Donghee Kim; Hwa Jung Kim; Jin Hwa Kang; Su Jin Chung; Min Jung Park; Young Sun Kim; Chung Hyun Kim; Seung Ho Choi; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Sang-Heon Cho; Myung-Whun Sung; Byung-Hee Oh
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

8.  Overweight and obesity: the pathogenesis of cardiometabolic risk.

Authors:  George A Bray; Michael B Clearfield; Dan J Fintel; Donald S Nelinson
Journal:  Clin Cornerstone       Date:  2009

Review 9.  Non-alcoholic fatty liver disease in 2016.

Authors:  S A Townsend; Philip N Newsome
Journal:  Br Med Bull       Date:  2016-08-19       Impact factor: 4.291

10.  Association between retinal artery lesions and nonalcoholic fatty liver disease.

Authors:  Wen Yang; Hongtao Xu; Xiaohong Yu; Yuzhu Wang
Journal:  Hepatol Int       Date:  2015-02-15       Impact factor: 6.047

View more
  4 in total

1.  The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.

Authors:  Maobin Kuang; Guotai Sheng; Chong Hu; Song Lu; Nan Peng; Yang Zou
Journal:  Lipids Health Dis       Date:  2022-10-20       Impact factor: 4.315

2.  The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Yuxian Yang; Shuting Li; Yuechao Xu; Jing Ke; Dong Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-11       Impact factor: 3.249

3.  The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran.

Authors:  Ladan Aghakhani; Neda Haghighat; Masoud Amini; Seyed Vahid Hosseini; Seyed Jalil Masoumi
Journal:  Gastroenterol Res Pract       Date:  2022-02-07       Impact factor: 2.260

4.  Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features via Bioinformatics Methods.

Authors:  Ziyu Liu; Yufei Li; Caihong Yu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.